nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A polygenic risk score for breast cancer risk in a Taiwanese population
|
Hsieh, Yi-Chen |
|
2017 |
163 |
1 |
p. 131-138 |
artikel |
2 |
A single-institution experience of salvage therapy for patients with early and locally advanced breast cancer who progress during neoadjuvant chemotherapy
|
Raphael, Jacques |
|
2017 |
163 |
1 |
p. 11-19 |
artikel |
3 |
Characteristics of BRCA1/2 mutations carriers including large genomic rearrangements in high risk breast cancer patients
|
Park, Boyoung |
|
2017 |
163 |
1 |
p. 139-150 |
artikel |
4 |
Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients
|
Goorts, Briete |
|
2017 |
163 |
1 |
p. 83-91 |
artikel |
5 |
Complications and thromboembolic events associated with tamoxifen therapy in patients with breast cancer undergoing microvascular breast reconstruction: a systematic review and meta-analysis
|
Parikh, Rajiv P. |
|
2017 |
163 |
1 |
p. 1-10 |
artikel |
6 |
Co-targeting the HER and IGF/insulin receptor axis in breast cancer, with triple targeting with endocrine therapy for hormone-sensitive disease
|
Chakraborty, Ashok |
|
2017 |
163 |
1 |
p. 37-50 |
artikel |
7 |
Erratum to: Diagnostic performance of tomosynthesis and breast ultrasonography in women with dense breasts: a prospective comparison study
|
Kim, Won Hwa |
|
2017 |
163 |
1 |
p. 197 |
artikel |
8 |
Higher densities of Foxp3+ regulatory T cells are associated with better prognosis in triple-negative breast cancer
|
Yeong, Joe |
|
2017 |
163 |
1 |
p. 21-35 |
artikel |
9 |
High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function
|
Yndestad, Synnøve |
|
2017 |
163 |
1 |
p. 177-190 |
artikel |
10 |
Management of small T1a/b breast cancer by tumor subtype
|
Ignatov, Tanja |
|
2017 |
163 |
1 |
p. 111-118 |
artikel |
11 |
Oncologist and organizational factors associated with variation in breast cancer multigene testing
|
Lieu, Tracy A. |
|
2017 |
163 |
1 |
p. 167-176 |
artikel |
12 |
Oncotype DX breast cancer recurrence score can be predicted with a novel nomogram using clinicopathologic data
|
Orucevic, Amila |
|
2017 |
163 |
1 |
p. 51-61 |
artikel |
13 |
Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases
|
Nijnatten, T. J. A. van |
|
2017 |
163 |
1 |
p. 159-166 |
artikel |
14 |
Retrospective review of genomic testing in breast cancer: Does it improve outcome?
|
Gastelum, Grady M. |
|
2017 |
163 |
1 |
p. 191-195 |
artikel |
15 |
Risk factors associated with the triple-negative breast cancer subtype within four race/ethnicities
|
Parise, Carol A. |
|
2017 |
163 |
1 |
p. 151-158 |
artikel |
16 |
Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology
|
Inwald, EC |
|
2017 |
163 |
1 |
p. 119-130 |
artikel |
17 |
Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer
|
Zetterlund, Linda Holmstrand |
|
2017 |
163 |
1 |
p. 103-110 |
artikel |
18 |
Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer
|
Zetterlund, Linda |
|
2017 |
163 |
1 |
p. 93-101 |
artikel |
19 |
The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer
|
Thomas, J. S. |
|
2017 |
163 |
1 |
p. 63-69 |
artikel |
20 |
The influences of peritumoral lymphatic invasion and vascular invasion on the survival and recurrence according to the molecular subtypes of breast cancer
|
Hwang, Ki-Tae |
|
2017 |
163 |
1 |
p. 71-82 |
artikel |